BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15719643)

  • 21. [Changes in serum lipid and lipoproteins in alloxan-diabetic rats--studies for one year].
    Arisue K; Uchida K; Takeuchi N
    Jikken Dobutsu; 1994 Apr; 43(2):217-26. PubMed ID: 8174623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidiabetic activity of Bauhinia forficata extracts in alloxan-diabetic rats.
    Lino Cde S; Diógenes JP; Pereira BA; Faria RA; Andrade Neto M; Alves RS; de Queiroz MG; de Sousa FC; Viana GS
    Biol Pharm Bull; 2004 Jan; 27(1):125-7. PubMed ID: 14709915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential changes in serum glucose, triglycerides and cholesterol in aging of normal and alloxan-diabetic rats.
    Altura BM; Lum G; Turlapaty PD; Altura BT
    Experientia; 1981 Mar; 37(3):224-6. PubMed ID: 7238769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Ethanolic Leaf Extract of Senna Fistula on some Haematological Parameters, Lipid Profile and Oxidative Stress in Alloxan-induced Diabetic Rats.
    Ayinla TM; Owoyele VB; Yakubu TM
    Niger J Physiol Sci; 2015 Dec; 30(1-2):87-93. PubMed ID: 27507782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Acacia nilotica fruit extract on serum glucose and lipid concentrations in alloxan-induced diabetic rats.
    Abuelgassim AO
    Pak J Biol Sci; 2013 Nov; 16(21):1398-402. PubMed ID: 24511755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoglycemic and hypolipidemic effects of protein hydrolysates from zebra blenny (Salaria basilisca) in alloxan-induced diabetic rats.
    Ktari N; Mnafgui K; Nasri R; Hamden K; Bkhairia I; Ben Hadj A; Boudaouara T; Elfeki A; Nasri M
    Food Funct; 2013 Nov; 4(11):1691-9. PubMed ID: 24104463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats.
    Abd El Sattar El Batran S; El-Gengaihi SE; El Shabrawy OA
    J Ethnopharmacol; 2006 Nov; 108(2):236-42. PubMed ID: 16815658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term treatment in vivo with NOX-101, a scavenger of nitric oxide, prevents diabetes-induced endothelial dysfunction.
    Pieper GM; Dembny K; Siebeneich W
    Diabetologia; 1998 Oct; 41(10):1220-6. PubMed ID: 9794111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catalase activity, lipid peroxidation, cholesterol and triglyceride levels in alloxan--induced diabetes mellitus in female and male rats.
    Ebuehi OA; Ajuluchukwu AE; Afolabi OT; Ebuehi OM; Akinwande AI
    Nig Q J Hosp Med; 2009; 19(1):15-9. PubMed ID: 20830981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired contraction and relaxation in the aorta of streptozotocin-diabetic rats.
    Utkan T; Sarioglu Y; Yildirim S
    Pharmacology; 1998 Apr; 56(4):207-15. PubMed ID: 9566022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rosiglitazone, a peroxisome proliferator-activated receptor γ stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity.
    El-Bassossy HM; Abo-Warda SM; Fahmy A
    Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):643-9. PubMed ID: 22594672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma endothelin levels and vascular responses at different temporal stages of streptozotocin diabetes.
    Hopfner RL; McNeill JR; Gopalakrishnan V
    Eur J Pharmacol; 1999 Jun; 374(2):221-7. PubMed ID: 10422763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of gemfibrozil treatment on vascular reactivity of streptozotocin-diabetic rat aorta.
    Ozansoy G; Akin FB
    J Pharm Pharmacol; 2004 Feb; 56(2):241-6. PubMed ID: 15005883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in vascular responses to vasoactive agents of basilar artery and aorta from rabbits with alloxan-induced diabetes.
    Abiru T; Kamata K; Miyata N; Kasuya Y
    Can J Physiol Pharmacol; 1990 Jul; 68(7):882-8. PubMed ID: 1696518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of antidiabetic potential of oyster mushroom (Pleurotus ostreatus) in alloxan-induced diabetic mice.
    Ravi B; Renitta RE; Prabha ML; Issac R; Naidu S
    Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):101-9. PubMed ID: 22867521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidiabetic and antioxidant effects of oleanolic acid from Ligustrum lucidum Ait in alloxan-induced diabetic rats.
    Gao D; Li Q; Li Y; Liu Z; Fan Y; Liu Z; Zhao H; Li J; Han Z
    Phytother Res; 2009 Sep; 23(9):1257-62. PubMed ID: 19274687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the Anti-Diabetic Activity of Polysaccharide from Cordyceps cicadae in Experimental Diabetic Rats.
    Zhang Q; Olatunji OJ; Chen H; Tola AJ; Oluwaniyi OO
    Chem Biodivers; 2018 Aug; 15(8):e1800219. PubMed ID: 29874416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin.
    Pieper GM
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):8-15. PubMed ID: 9007664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contractile responses in spontaneously diabetic mice. I. Involvement of superoxide anion in enhanced contractile response of aorta to norepinephrine in C57BL/KsJ(db/db) mice.
    Kanie N; Kamata K
    Gen Pharmacol; 2000 Dec; 35(6):311-8. PubMed ID: 11922961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fucoidan from Sargassum wightii reduces oxidative stress through upregulating Nrf2/HO-1 signaling pathway in alloxan-induced diabetic cardiomyopathy rats.
    Puhari SSM; Yuvaraj S; Vasudevan V; Ramprasath T; Arunkumar K; Amutha C; Selvam GS
    Mol Biol Rep; 2023 Nov; 50(11):8855-8866. PubMed ID: 37665545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.